Injectable allogeneic bone mesenchymal stem cells: A potential minimally invasive therapy for atrophic nonunion

Medical Hypotheses

Volumn 77, Issue 5, 2011, Pages 912-913

  Zhao, Zhenyu ^a   Hao, Chenguang ^a   Zhao, Hongmei ^b   Liu, Jianyu ^a   Shao, Lin ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BONE ATROPHY; BONE CELL; FRACTURE NONUNION; HYPOTHESIS; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INJECTION; MESENCHYMAL STEM CELL; MINIMALLY INVASIVE PROCEDURE;

BONE AND BONES; FIBRIN TISSUE ADHESIVE; HUMANS; MESENCHYMAL STEM CELLS; MODELS, THEORETICAL; STEM CELL TRANSPLANTATION;

EID: 80053987400     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.08.009     Document Type: Article

References (21)

1. Braun W., Ruter A. Fracture healing. Morphologic and physiologic aspects. Unfallchirurg 1996, 99:59-67.
2. Arrington E.D., Smith W.J., Chambers H.G., et al. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res 1996, 329:300-309.
3. Bensaid W., Triffitt J.T., Blanchat C., et al. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 2003, 24:2497-2502.
4. Lee K.B., Hui J.H., Song I.C., et al. Injectable mesenchymal stem cell therapy for large cartilage defects-a porcine model. Stem Cells 2007, 25:2964-2971.
5. Park H., Temenoff J.S., Tabata Y., et al. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 2007, 28:3217-3227.
6. Cetrulo C.L., Knox K.R., Brown D.J., et al. Stem cells and distraction osteogenesis: endothelial progenitor cells home to the ischemic generate in activation and consolidation. Plast Reconstr Surg 2005, 116:1053-1064.
7. Trojani C., Boukhechba F., Scimeca J.C., Vandenbos F., Michiels J.F., Daculsi G., et al. Ectopic bone formation using an injectable biphasic calcium phosphate/Si-HPMC hydrogel composite loaded with undifferentiated bone marrow stromal cells. Biomaterials 2006, 27:3256-3264.
8. Viateau V., Guillemin G., Bousson V., et al. Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep. J Orthop Res 2007, 25:741-749.
9. Zhao Z., Yang D., Ma X., et al. Successful repair of a critical-sized bone defect in the rat femur with a newly developed external fixator. Tohoku J Exp Med 2009, 219:115-120.
10. Kirker-Head C., Karageorgiou V., Hofmann S., et al. BMP-silk composite matrices heal critically sized femoral defects. Bone 2007, 41:247-255.
11. Peters A., Toben D., Lienau J., et al. Locally applied osteogenic predifferentiated progenitor cells are more effective than undifferentiated mesenchymal stem cells in the treatment of delayed bone healing. Tissue Eng 2009, 15:2947-2954.
12. Bruder S.P., Jaiswal N., Haynesworth S.E. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997, 64:278-294.
13. Tsuchida H., Hashimoto J., Crawford E., et al. Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats. J Orthop Res 2003, 21:44-53.
14. Kruyt M., de Bruijn J., Rouwkema J., et al. Analysis of the dynamics of bone formation, effect of cell seeding density, and potential of allogeneic cells in cell-based bone tissue engineering in goats. Tissue Eng 2008, 14:1081-1088.
15. Arinzeh T.L., Peter S.J., Archambault M.P., et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003, 85-A:1927-1935.
16. Di Nicola M., Carlo-Stella C., Magni M., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
17. Bartholomew A., Sturgeon C., Siatskas M., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002, 30:42-48.
18. Griffin M.D., Ritter T., Mahon B.P. Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 2010, 21:1641-1655.
19. Devine S.M., Peter S., Martin B.J., et al. Mesenchymal stem cells: stealth and suppression. Cancer J 2001, 7(Suppl 2):S76-S82.
20. Catelas I., Sese N., Wu B.M., et al. Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng 2006, 12:2385-2396.
21. Proulx M.K., Carey S.P., Ditroia L.M., et al. Fibrin microthreads support mesenchymal stem cell growth while maintaining differentiation potential. J Biomed Mater Res A 2011, 96:301-312.